verve therapeutics stock prediction

In the short term 2weeks VERVs. Verve Therapeutics Stock Prediction.


S 1

The current price Verve Therapeutics VERV is trading at is 3428 which is within the analysts predicted range.

. This is based on 5 Wall Streets Analysts 12-month price targets issued in the past 3 months. Verve Therapeutics has a 52-week low of 1070 and a 52-week high of 5096. The current Verve Therapeutics VERV share price is 3232.

Browse analyst ratings and price targets on all stocks. Stock Predictons by days. Shares of NASDAQ VERV opened at 2338 on Thursday.

2025 Search Stock FX pair Crypto or Commodity. Stock USD 1526 024 155 Verve Therapeutics stock price prediction is an act of determining the future value of Verve Therapeutics shares using few different conventional. The Score for VERV is 54 which is 8 above its historic median score of 50 and infers lower risk than normal.

View Verve Therapeutics Inc VERV investment stock information. VERV a clinical-stage gene-editing biopharmaceutical that focuses on cardiovascular therapies saw its share price plummet 2633 as of Monday. The average price target for Verve Therapeutics is 5140.

Stock price fell by -0242 on the last day Monday 14th Nov 2022 from 2688 to 2682. The current Verve Therapeutics VERV share price is 3634. The highest analyst price target.

The businesss fifty day simple moving. Verve Therapeutics VERV stock is taking a beating on Monday following bad news from the US. Featuring AI generated news summaries.

The Score for VERV is 43 which is 14 below its historic median score of 50 and infers higher risk than normal. 2021 Search Stock FX pair Crypto or Commodity. Verve Therapeutics has received a consensus rating of Buy.

Why Is Verve Therapeutics VERV Stock Down 28 Today. Verve Therapeutics Inc Stock Forecast and Price Prognosis Data for 2025. The forecast for the further price development based.

Food and Drug Administration. Shares of Verve Therapeutics stock opened at 2338 on Thursday. Verve Therapeutics VERV adaptive stock price forecast ideologically balanced news.

According to the issued ratings of 5 analysts in the last year the consensus. What is Verve Therapeuticss consensus rating and price target. Get the latest Verve Therapeutics Inc VERV detailed stock quotes stock data Real-Time ECN charts stats and.

The firm has a 50 day moving average price of. Verve Therapeutics Inc Stock Forecast and Price Prognosis Data for 2021. VERV stock forecast Our latest prediction for Verve Therapeutics Incs stock price was made on the July 15 2022 when the stock price was at 2371.

The Verve Therapeutics Inc. During the last trading day the stock fluctuated 756 from a. Stock Predictons by days.

Machine learning powered price prediction. The last closing price of the Verve Therapeutics Inc share was 1971 and has changed by -423 since the penultimate trading day. The companys average rating score is 280 and is based on 4 buy ratings 1 hold rating and no sell ratings.

VERV Price Target - Frequently Asked Questions. Verve Therapeutics Stock Prediction. As of 2022 October 27 Thursday current price of VERV stock is 37000 and our data indicates that the asset price has been in a downtrend for the past 1 year or since its inception.

Verve Therapeutics has a 52 week low of 1070 and a 52 week high of 5096.


Ipo Investment Prospectus S 1


Verv Stock Forecast Price News Verve Therapeutics


44 Thriving Biotech Startups 2022


Verv Stock Forecast Price Targets And Analysts Predictions Tipranks


Verve Therapeutics Inc 2021 Annual Report 10 K


Ipo Investment Prospectus S 1


Cathie Wood Bets Big On These 2 Strong Buy Stocks Nasdaq


Verve Therapeutics Share Price Nsq Verv Stock Research Stockopedia


Beam Stock Price And Chart Nasdaq Beam Tradingview


Verve Therapeutics Inc Verv Stock Price News Info The Motley Fool


Beam Stock Price And Chart Nasdaq Beam Tradingview


Dice Stock Forecast Price News Dice Therapeutics


A Structural Variation Reference For Medical And Population Genetics Nature


Verv Stock Forecast Price News Verve Therapeutics


Leveraging Fine Mapping And Multipopulation Training Data To Improve Cross Population Polygenic Risk Scores Nature Genetics


Verve Therapeutics Inc Verv Stock Price News Info The Motley Fool


Inherited Causes Of Clonal Haematopoiesis In 97 691 Whole Genomes Nature


We Think Verve Therapeutics Nasdaq Verv Can Afford To Drive Business Growth Nasdaq


Ipo Investment Prospectus S 1

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel